Media Room--We can provide journalists with expert commentary on topics like:  

  • Challenges facing early career scientists, and new technologies and trends in cancer research (all forms of cancer)
  • Connections to bright, articulate early career scientists involved in leading-edge cancer research projects
  • Introductions to scientists and doctors nationwide, and interviews with our President and CEO, Chief Scientific Officer, or others

Contact: Ronni Berke, Director of Communications and Marketing, ronni.berke@damonrunyon.org, 212.455.0504 

Press releases are listed below.  Visit New Discoveries for breakthroughs from our scientists.

Mission: To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. The Foundation supports emerging leaders who have great potential to achieve breakthroughs in how we diagnose, treat and prevent cancer. Since its founding in 1946, the Foundation has invested nearly $355 million and funded nearly 3,700 young scientists. 100% of all donations to the Foundation are used to support scientific research. 

July 9, 2015

The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award, committing nearly $875,000 to help address a critical shortage of funding for pediatric cancer research.


June 30, 2015

To help increase the number of physician-scientists, the Damon Runyon Cancer Research Foundation has created a new award, the Damon Runyon Physician-Scientist Training Award, which provides physicians who have earned an MD degree and completed clinical specialty fellowship training the opportunity to gain the research skills and experience they need to become leaders in translational and clinical research. It announced that three scientists with novel approaches to fighting cancer have been named the 2015 recipients of the Damon Runyon Physician-Scientist Training Award.


June 23, 2015

The Damon Runyon Cancer Research Foundation named four new Damon Runyon Clinical Investigators at its spring 2015 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians. The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators.


May 5, 2015

The Damon Runyon Cancer Research Foundation honored Dmitri Stockton, President and CEO of GE Asset Management, at its 2015 Annual Breakfast, held on Tuesday morning at Cipriani 42nd Street in New York City. The Breakfast raised $1.5 million to support the nation’s best and brightest cancer researchers, fostering the talent capable of revolutionizing the prevention, detection, and treatment of all forms of cancer.


March 3, 2015

The Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer. Hosted by Lilly Oncology at the Alexandria Center™ for Life Science, New York City, the meeting included academic researchers from top universities and research institutions as well as scientists from Eli Lilly and Company, Celgene, Genentech, Merck, and Takeda Pharmaceuticals International Co.


January 30, 2015

The Damon Runyon Cancer Research Foundation named 15 new Damon Runyon Fellows at its fall Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Committee also named six new recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists. This award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation’s highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.


January 15, 2015

The Damon Runyon Cancer Research Foundation announced that six scientists with novel approaches to fighting cancer have been named 2015 recipients of the Damon Runyon-Rachleff Innovation Award. The two-year grant is awarded each year to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer. Each awardee will have the opportunity for up to two additional years of funding (up to four years total) based on demonstration of progress on their proposed research.


November 15, 2014

The recent ASCO Post featured an op-ed piece by Damon Runyon President and CEO Lorraine Egan, entitled “Why Physician-Scientists Are Indispensable to Cancer Research.” The op-ed describes why it is urgent that we take action to enable more doctors to follow this important career path and describes the launch of our new Physician-Scientist Training Award.


August 3, 2014

More than 2,300 baseball fans, runners, walkers, cancer survivors, and their friends and family gathered at Yankee Stadium on Sunday, August 3rd for the Damon Runyon Cancer Research Foundation’s sixth annual Runyon 5K. This year’s event raised more than $500,000 for the nonprofit’s groundbreaking efforts to strike out cancer. Since inception, the event has raised more than $3.5 million dollars.


July 14, 2014

The Damon Runyon Cancer Research Foundation named 16 new Damon Runyon Fellows at its spring Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country.